Work

GRECO-2: A randomized, phase 2 study of stereotactic body radiation therapy (SBRT) in combination with rucosopasem (GC4711) in the treatment of locally advanced or borderline resectable nonmetastatic pancreatic cancer.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.tps4184

Authors: Sarah E. Hoffe, Dae Won Kim, James Costello, Mokenge Peter Malafa, Todd Anthony Aguilera, Shaalan Shaalan Beg, Parag Parikh, Joseph M. Herman, Joseph Michael Caster, Maged Ghaly, Elizabeth Charlotte Moser, Kara Terry, Michael Kurman, Jon Holmlund

Institutions: Moffitt Cancer Center, The University of Texas Southwestern Medical Center, Henry Ford Health, Henry Ford Hospital, Northwell Health, University of Iowa Hospitals and Clinics, Galera Therapeutics, Inc. (United States)

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281743942

Cites:

Cited by: 1

Related to: 10